Skip to main content

Soleno Therapeutics Inc

SLNODelisted May 18, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001484565

Soleno Therapeutics Inc was delisted on May 18, 2026; its insiders filed their last Form 4 on May 18, 2026; 227 institutions reported holding it in 13F filings for Q1 2026, worth $2.09B in total; no superinvestor held it.

Q1 2025 vs. Q4 2024

How the institutions holding Soleno Therapeutics Inc changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of SLNO: Q4 2024 compared with Q1 2025
MeasureQ4 2024Of which not filed for Q1 2025Q1 2025Change
Holders1662217+53
Shares51.0M63.2K54.6M+3.59M (+7.0%)
Value$2.29B$2.84M$3.90B+$1.61B (+70.3%)

2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (70)

Institutions that held Soleno Therapeutics Inc at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to SLNO in Q1 2025
InstitutionSharesValue% of portfolio
Point72 Asset Management, L.P.915,995$65.4M0.18%
Polar Capital Holdings Plc500,000$35.7M0.22%
Capital World Investors464,833$33.2M0.01%
Assenagon Asset Management S.A.434,514$31.0M0.06%
Soros Fund Management LLCSuperinvestorSoros Fund Management270,663$19.3M0.34%
Driehaus Capital Management LLC247,737$17.7M0.17%
Tri Locum Partners LP234,920$16.8M8.61%
Silverarc Capital Management, LLC166,417$11.9M2.48%
Catalio Capital Management, LP160,962$11.5M2.85%
HSBC Holdings PLC152,957$10.9M0.01%
Soleus Capital Management, L.P.150,000$10.7M0.84%
Nuveen, LLC84,830$6.06M0.00%
Mutual of America Capital Management LLC72,582$5.19M0.06%
Acuta Capital Partners, LLC67,136$4.80M5.56%
EAM Global Investors LLC62,436$4.46M1.21%
Lord, Abbett & Co. LLC55,061$3.93M0.01%
Quadrature Capital Ltd51,762$3.69M0.08%
EAM Investors, LLC49,548$3.54M0.61%
Y-Intercept (Hong Kong) Ltd40,425$2.89M0.20%
Resolute Capital Asset Partners LLC40,000$2.86M1.61%
Universal- Beteiligungs- und Servicegesellschaft mbH36,495$2.61M0.01%
Schonfeld Strategic Advisors LLC35,706$2.55M0.02%
Gilder Gagnon Howe & Co LLC33,086$2.36M0.03%
Granahan Investment Management Inc32,491$2.32M0.12%
Avidity Partners Management LP32,000$2.29M0.47%
First Turn Management, LLC29,115$2.08M0.42%
Lisanti Capital Growth, LLC25,365$1.81M0.54%
Nomura Holdings Inc23,569$1.68M0.01%
SummitTX Capital, L.P.23,236$1.66M0.07%
Allostery Investments LP20,000$1.43M2.06%
Superstring Capital Management LP19,332$1.38M1.65%
Patient Square Capital LP18,600$1.33M0.55%
Trexquant Investment LP16,899$1.21M0.01%
D. E. Shaw & Co., Inc.16,672$1.19M0.00%
DRW Securities, LLC14,761$1.05M0.09%
Nebula Research & Development LLC14,469$1.03M0.10%
Virtu Financial LLC14,396$1.03M0.06%
Atom Investors LP14,301$1.02M0.13%
Boothbay Fund Management, LLC13,750$982.4K0.04%
StemPoint Capital LP11,155$797.0K0.25%
Sherbrooke Park Advisers LLC7,830$559.5K0.26%
Jain Global LLC5,797$414.2K0.01%
CIBC World Markets Corp5,677$405.6K0.00%
Two Sigma Securities, LLC5,278$377.1K0.06%
Envestnet Asset Management Inc4,413$315.3K0.00%
Legato Capital Management LLC4,335$309.7K0.04%
RWC Asset Management LLP4,306$307.7K0.02%
FORA Capital, LLC4,258$304.2K0.03%
Bridgefront Capital, LLC4,096$292.7K0.08%
Victory Capital Management Inc4,037$288.4K0.00%
Royce & Associates LP4,000$285.8K0.00%
Optimize Financial Inc3,838$274.2K0.10%
Glenmede Trust Co NA3,711$265.1K0.00%
Virtus Investment Advisers, Inc.3,543$253.1K0.07%
Oppenheimer & Co Inc3,253$232.4K0.00%
Point72 (DIFC) Ltd2,908$207.8K0.02%
Quarry LP1,700$121.5K0.03%
Centiva Capital, LP900$64.3K0.00%
Russell Investments Group, Ltd.21$1.50K0.00%
Jones Financial Companies LLLP20$1.44K0.00%
TD Private Client Wealth LLC10$7150.00%
Stephens Consulting, LLC10$7150.00%
Parkside Financial Bank & Trust10$7140.00%
EverSource Wealth Advisors, LLC8$5720.00%
Coldstream Capital Management Inc7$5010.00%
J.Safra Asset Management Corp7$5000.00%
Creative Financial Designs Inc5$3570.00%
CoreCap Advisors, LLC5$3570.00%
Signaturefd, LLC2$1430.00%
National Bank of Canada1$710.00%

Sold out (17)

Institutions that held Soleno Therapeutics Inc at the end of Q4 2024 and filed for Q1 2025 without it.

Not filed for Q1 2025 yet (2)

Institutions that held Soleno Therapeutics Inc at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SLNO in Q4 2024 that haven't filed for Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Nuveen Asset Management, LLC63,105$2.84M
Global Retirement Partners, LLC100$4.50K